financetom
Business
financetom
/
Business
/
BlackRock Activist Shareholder Saba Capital Details Plans for 10 Closed-End Funds; BlackRock Raises Distribution for 2 Funds
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BlackRock Activist Shareholder Saba Capital Details Plans for 10 Closed-End Funds; BlackRock Raises Distribution for 2 Funds
May 20, 2024 7:20 AM

09:51 AM EDT, 05/20/2024 (MT Newswires) -- BlackRock ( BLK ) activist shareholder Saba Capital on Monday released a presentation detailing its plans to change certain governance issues in 10 closed-end BlackRock ( BLK ) funds.

Saba said it would support a tender offer for five of the funds -- Innovation and Growth Term Trust, Health Sciences Term Trust, ESG Capital Allocation Term Trust, Capital Allocation Term Trust and Science and Technology Term Trust -- which would be fair given their "horrendous performance."

The investor had previously proposed to terminate BlackRock's ( BLK ) investment management agreement at the five funds and the California Municipal Income Trust. If the termination follows through, Saba said its board nominees have a "credible plan" to find a new manager for the funds.

Additionally, shareholders of the funds should be given one vote per share, Saba said. It noted that, currently, not voting in seven out of the 10 funds would automatically count for BlackRock ( BLK ).

Separately, BlackRock ( BLK ) said Monday it increased the distribution for the MuniYield Pennsylvania Quality Fund by 38% to $0.066 per share and for the California Municipal Income Trust by 16% to $0.059 apiece. "We have taken this step to support shareholders of these funds, consistent with our goal of delivering long-term value," said R. Glenn Hubbard, BlackRock's ( BLK ) chair for closed-end funds.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
New Analysis of Omeros' Narsoplimab to Treat Complications From Stem Cell Transplant Support Results
New Analysis of Omeros' Narsoplimab to Treat Complications From Stem Cell Transplant Support Results
Jan 16, 2025
02:17 PM EST, 01/16/2025 (MT Newswires) -- Omeros ( OMER ) said Thursday that results from a statistical analysis of narsoplimab, its monoclonal antibody to treat hematopoietic stem cell transplant-associated thrombotic microangiopathy, or TA-TMA, showed robustness of the previously reported primary endpoint analysis. The company said that newly completed sensitivity analyses confirm the survival benefit of narsoplimab in patients with...
Citigroup axes more jobs, Bloomberg reports
Citigroup axes more jobs, Bloomberg reports
Jan 16, 2025
Jan 16 (Reuters) - Citigroup ( C/PN ) is cutting more jobs this week to meet Jane Fraser's expense goals, Bloomberg News reported on Thursday, citing people familiar with the matter. ...
Leafly Shares Dive After Nasdaq's Delisting Notice
Leafly Shares Dive After Nasdaq's Delisting Notice
Jan 16, 2025
02:17 PM EST, 01/16/2025 (MT Newswires) -- Leafly ( LFLY ) shares plunged about 50% in recent Thursday trading after the firm said the Nasdaq Hearings Panel determined to delist its shares from the exchange due partly to its failure to comply with net income listing requirement. Trading in shares and warrants will be suspended with the opening of trading...
Super Micro Computer Shares Are On The Rise: What's Going On?
Super Micro Computer Shares Are On The Rise: What's Going On?
Jan 16, 2025
Super Micro Computer, Inc. ( SMCI ) shares are trading higher Thursday after the prominent short-selling firm Hindenburg Research announced its closure. What To Know: Hindenburg, known for high-profile short reports, accused Super Micro Computer ( SMCI ) last year of accounting manipulation, sibling self-dealing, and sanctions evasion, triggering significant scrutiny of the company. The firm, founded in 2017 by...
Copyright 2023-2026 - www.financetom.com All Rights Reserved